• HTG Transcriptome
    Panel Available Now

    Simplify gene expression analysis with our new comprehensive human transcriptome panel.

    Learn More 

  • VERI/O Laboratory Services

    It's not business, it's personal.
    We treat our partners like colleagues and your study like our own.

    Learn More 

  • HTG EdgeSeq Panels

    The most fragile RNA samples can now reveal the greatest insights for gene expression and biomarker discovery.

    Learn More 

  • HTG EdgeSeq Systems

    Devlivering extraction-free RNA molecular profiling solutions and semi-automated library prep.

    Learn More 

Harness the Power of HTG's Propietary Transcriptome Panel

Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG's RNA platform technologies make the development of life science tools and diagnostics more effective and cost-efficient, enabling researchers to interrogate the entire transcriptome with smaller sample requirements and higher success rates.

Featured Publication

Overview of the Design and Performance of the HTG Transcriptome Panel

This White Paper summarizes the data generated using the HTG Transcriptome Panel from Feasibility through Verification, including comparison to RNA-Seq.
 

READ PUBLICATION

HTG Molecular News & Events

2022 ASCO Annual Meeting

June 3-7 | Join us at booth 3135 in Chicago at the 2022 ASCO Annual Meeting and Expo.

Posted on:

Keep Reading

ESMO CONGRESS 2022

SEPTEMBER 9-13, 2022 | Join us at the European Society for Medical Oncology Congress in Paris, France

Posted on:

Keep Reading

The Festival of Genomics & Biodata 2023

January 25-26 | Come and see us in London at the 2023 Festival of Genomics

Posted on:

Keep Reading

HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference

TUCSON, Ariz. , May 17, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate virtually in the H.C….

Keep Reading

HTG Molecular Diagnostics Reports First Quarter 2022 Results

Call scheduled for today, May 12, at 4:30 pm ET TUCSON, Ariz. , May 12, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business…

Keep Reading

HTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12

TUCSON, Ariz. , May 05, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended…

Keep Reading

Resources

Find product information, specifications and gene lists here. 

Case Studies

Brochures

Gene Lists

Product Sheets

Tech Notes

Safety Data Sheets

Videos

Webinars


Support

Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or panels. 

Log in to your account

Page last updated January 31, 2022

Ready to get started?

HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.

Get in Touch